1. Home
  2. IMRN vs MRM Comparison

IMRN vs MRM Comparison

Compare IMRN & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

SELL

Current Price

$0.88

Market Cap

7.7M

Sector

Health Care

ML Signal

SELL

Logo MEDIROM Healthcare Technologies Inc.

MRM

MEDIROM Healthcare Technologies Inc.

SELL

Current Price

$0.23

Market Cap

7.6M

ML Signal

SELL

Company Overview

Basic Information
Metric
IMRN
MRM
Founded
1994
2000
Country
Australia
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
7.6M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
IMRN
MRM
Price
$0.88
$0.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.4K
★ 50.9K
Earning Date
08-28-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$32.01
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.22
52 Week High
$1.99
$2.33

Technical Indicators

Market Signals
Indicator
IMRN
MRM
Relative Strength Index (RSI) 34.56 21.39
Support Level $0.75 N/A
Resistance Level $0.89 $0.84
Average True Range (ATR) 0.07 0.04
MACD 0.00 0.01
Stochastic Oscillator 22.05 13.08

Price Performance

Historical Comparison
IMRN
MRM

About IMRN Immuron Limited

Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.

About MRM MEDIROM Healthcare Technologies Inc.

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

Share on Social Networks: